© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Silo Pharma, Inc. (SILO) shows an Average True Range (ATR) of 0.03 and an Enterprise Value of 1.82M. Its average trading volume over the past 3 months is 400.08K, indicating liquidity. These fundamental metrics provide insight into SILO's underlying financial health and market activity.
Silo Pharma, Inc. (SILO) technical indicators as of January 1, 2026: the SMA 20 is -16.14%, SMA 50 at -24.48%, and SMA 200 at -49.58%. The RSI 14 value is 34.99, suggesting its current momentum. These technical analysis signals help assess SILO's price trends and potential future movements.
Silo Pharma, Inc. (SILO) stock performance overview as of January 1, 2026: The 52-week high is $3.37 (currently -89.91% below), and the 52-week low is $0.325 (currently 4.58% above). Over the past year, SILO's performance is -64.53%, compared to the S&P 500's 12.29% change.
According to market data, Silo Pharma, Inc. (SILO) stock's recent performance metrics show that over the last month, SILO is -26.9%, with a Year-to-Date (YTD) performance of -61.8%. Over the past year, the stock has seen a -64.53% change. These figures summarize SILO's price movements across various periods, reflecting its historical returns.
According to current financial data, SILO stock's P/E (TTM) ratio is -0.60, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for SILO, including P/S (36.19), P/B (0.61), and P/FCF (-0.54), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.